4 Stocks That Are Trading Far, Far Too Cheaply: AstraZeneca plc, Old Mutual plc, Aberdeen Asset Management plc And Rolls-Royce Holding PLC

Royston Wild explains why now is the time to stock up on AstraZeneca plc (LON: AZN), Old Mutual plc (LON: OML), Aberdeen Asset Management plc (LON: ADN) and Rolls-Royce Holding PLC (LON: RR).

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Today I am looking at four blue-chip barnstormers that should be attracting glances from all savvy value hunters.

AstraZeneca

I believe that pills play AstraZeneca (LSE: AZN) is a great way to cotton onto terrific long-term earnings growth. Sure, the issue of exclusivity losses across key products like Nexium and Crestor are sure to trouble the London business for a little while longer. But with the firm’s product pipeline already showing signs of significant improvement, and AstraZeneca leading the pack in terms of developing market demand, I fully expect the top-line to surge beyond the medium term.

For 2015 the pharma giant is expected to see earnings edge 3% higher, although a 2% dip is predicted for the following year. Despite this relative stagnation, these figures still leave the business dealing on P/E ratios of 15.1 times and 15.3 times for 2015 and 2016 respectively, around the benchmark of 15 times that represents attractive value. And a predicted dividend of 290 cents per share through to the close of next year yields an impressive 4.4%.

Old Mutual

Supported by its unrivalled exposure to promising African markets, I reckon life insurer Old Mutual (LSE: OML) is in great shape to enjoy resplendent sales growth. The London-headquartered firm is a major player in the regional engine of South Africa, and remains committed to expanding its footprint across the continent — just this month Old Mutual secured a majority stake in UAP Holdings, the financial services provider centred on Central and East African markets.

The City expects Old Mutual to benefit massively from the relatively-low market penetration of these regions, and earnings expansion of 9% and 11% is pencilled in for 2015 and 2016 correspondingly, creating brilliant P/E readings of 10.2 times and 9.7 times. Such solid growth is expected to translate through to the dividend, and payments of 9.7p per share and 10.6p are predicted for 2015 and 2016 correspondingly. Consequently Old Mutual sports vast yields of 4.7% and 5.2% for these years.

Aberdeen Asset Management

With investor activity firmly back on the turn, I believe that Aberdeen Asset Management (LSE: ADN) can look forward to splendid earnings growth once again. The firm raised eyebrows this month by deciding to raise £100m via a preference share issue to Mitsubishi UFJ Trust and Banking Corporation, with the fundraising designed “to meet customer needs and with a view to generating organic growth in those funds over time.”

The move naturally raised questions over Aberdeen Asset Management’s balance sheet, but the City believes the firm’s remains financially robust enough continue to hike the dividend, with estimated payouts of 19.9p per share for the year concluding September 2015, and 22p for 2016 producing jumbo yields of 4.9% and 5.4%. Indeed, the fund manager’s brilliant dividend outlook is underpinned by anticipated earnings growth of 3% and 8% in 2015 and 2016 respectively, projections that create decent P/E multiples of 12.4 times and 11.4 times.

Rolls-Royce Holding

With civil passenger numbers continuing to head through the roof, I believe that planebuilders like Boeing and Airbus can look forward to stapling fresh pages into their already-bulging order books amid rocketing airline profits. This is of course great news for Rolls-Royce (LSE: RR), whose Trent engines are a popular pick for flyers across the globe, while its TotalCare maintenance packages also set the industry standard.

Constrained spend in the oil market is expected to send earnings at ‘Double R’ 10% lower in 2015, although this still leaves the business dealing on a great earnings multiple of 15.3 times. And the ratio falls to 14.7 for next year amid expectations of a 6% bottom-line bounce. And Rolls-Royce’s bubbly long-term outlook is expected to keep dividends rumbling higher, with forecast payouts of 23.7p for 2015 and 26p for next year producing tasty yields of 2.6% and 2.9%.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Royston Wild has no position in any shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Affectionate Asian senior mother and daughter using smartphone together at home, smiling joyfully
Investing Articles

How I’d invest my first £20k ISA to target £4,900 a year from dividend shares

Looking for dividend shares in a new Stocks and Shares ISA, and want diversification too? Here's how I'd go about…

Read more »

Passive income text with pin graph chart on business table
Investing Articles

Yields of up to 7%! I’d consider boosting my income with these FTSE dividend stocks

The London market has some decent-looking dividend stocks right now, and I’m tempted by these two for growing income streams.

Read more »

Young mixed-race couple sat on the beach looking out over the sea
Investing Articles

I’d put £20K in an ISA now to target a £1,900 monthly second income in future!

Christopher Ruane shares why he thinks a long-term approach to investing and careful selection of shares could help him build…

Read more »

Mature couple at the beach
Investing Articles

6 stocks that Fools have been buying!

Our Foolish freelancers are putting their money where their mouths are and buying these stocks in recent weeks.

Read more »

Black woman using loudspeaker to be heard
Investing Articles

I was right about the Barclays share price! Here’s what I think happens next

Jon Smith explains why he still feels the Barclays share price is undervalued and flags up why updates on its…

Read more »

Investing Articles

Where I’d start investing £8,000 in April 2024

Writer Ben McPoland highlights two areas of the stock market that he would target if he were to start investing…

Read more »

View of Tower Bridge in Autumn
Investing Articles

Ahead of the ISA deadline, here are 3 FTSE 100 stocks I’d consider

Jon Smith notes down some FTSE 100 stocks in sectors ranging from property to retail that he thinks could offer…

Read more »

Young female business analyst looking at a graph chart while working from home
Investing Articles

Why I think Rolls-Royce shares will pay a dividend in 2024

Stephen Wright thinks Rolls-Royce shares are about to pay a dividend again. But he isn’t convinced this is something investors…

Read more »